Zangerle John Adam
Officer at STE; Sr. VP, Gen Counsel, and Sec. at Steris plc; VP, Gen Counsel, and Sec. at STERIS CORP
- Sold, on record
- $12.9M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Jun 15, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- STESTERIS plcOfficer
- Steris plcSr. VP, Gen Counsel, and Sec.
- STERIS CORPVP, Gen Counsel, and Sec.
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- STE48,808 shares
- Steris plc21,750 shares
- STERIS CORP7,925 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale STEPlan not statedApr 20, 2022 2022
Sold 8,000 shares at $255.48 ($2M)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
Sold 20.5% of holdings ($10M position)31,023 shares leftFiling
- 2 Form 4 sale STEPlan not statedJun 15, 2022 +56 days
Sold 2,659 shares at $205.31 ($546k)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
Sold 8.7% of holdings ($6.3M position)27,936 shares left0.3x usual sizeFiling
- 3 Form 144 notice STENoticeJun 13, 2025 +1094 days
Filed to sell 1,978 shares ($478k)
Zangerle John Adam, Officer
10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale STERoutineJun 13, 2025 same day
Sold 1,978 shares at $241.45 ($478k)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
10b5-1 planSold 5.5% of holdings ($8.6M position)33,760 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 4 sale STEUnusualNov 11, 2025 +151 days
Sold 15,000 shares at $265.14 ($4M)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
No 10b5-1 planSold 30.8% of holdings ($12.9M position)33,669 shares leftFiling
- 6 Form 144 notice STENoticeNov 12, 2025 +1 day
Filed to sell 15,000 shares ($4M)
Zangerle John Adam, Officer
No 10b5-1 planFiling
- 7 Form 144 notice STENoticeJun 15, 2026 +215 days
Filed to sell 1,419 shares ($297k)
Zangerle John Adam, Officer
10b5-1 planFiling
- 8 Form 4 sale STERoutineJun 15, 2026 same day
Sold 1,419 shares at $209.28 ($297k)
Zangerle John Adam, Sr. VP, Gen Counsel, and Sec.
10b5-1 planSold 3.9% of holdings ($7.7M position)35,259 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 16, 2026 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,419 | $297k | 3.9% | Routine | SEC |
| Jun 15, 2026 | Jun 15, 2026 | STE | Officer | Form 144 notice | 1,419 | $297k | Notice | SEC | |
| Nov 12, 2025 | Nov 12, 2025 | STE | Officer | Form 144 notice | 15,000 | $4M | Notice | SEC | |
| Nov 11, 2025 | Nov 13, 2025 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 15,000 | $4M | 30.8% | Unusual | SEC |
| Jun 13, 2025 | Jun 17, 2025 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,978 | $478k | 5.5% | Routine | SEC |
| Jun 13, 2025 | Jun 13, 2025 | STE | Officer | Form 144 notice | 1,978 | $478k | Notice | SEC | |
| Jun 15, 2022 | Jun 17, 2022 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 2,659 | $546k | 8.7% | Plan not stated | SEC |
| Apr 20, 2022 | Apr 21, 2022 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 8,000 | $2M | 20.5% | Plan not stated | SEC |
| Oct 1, 2020 | Oct 2, 2020 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 12,252 | $2.2M | 29.8% | Unusual | SEC |
| Sep 14, 2020 | Sep 15, 2020 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 2,000 | $334k | 6.5% | Plan not stated | SEC |
| Feb 11, 2020 | Feb 13, 2020 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 3,000 | $486k | 9.5% | Plan not stated | SEC |
| Oct 4, 2019 | Oct 7, 2019 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,000 | $142k | 3.4% | Plan not stated | SEC |
| May 31, 2019 | Jun 3, 2019 | STE | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,500 | $198k | 4.5% | Plan not stated | SEC |
| Jan 25, 2019 | Jan 28, 2019 | Steris plc | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 3,000 | $345k | 8.9% | Plan not stated | SEC |
| Jan 11, 2019 | Jan 14, 2019 | Steris plc | Sr. VP, Gen Counsel, and Sec. | Form 4 sale | 1,750 | $193k | 5.4% | Plan not stated | SEC |
| Nov 14, 2017 | Nov 15, 2017 | Steris plc | VP, Gen Counsel, and Sec. | Form 4 sale | 3,650 | $321k | 11.6% | Plan not stated | SEC |
| Jun 1, 2017 | Jun 2, 2017 | Steris plc | VP, Gen Counsel, and Sec. | Form 4 sale | 4,900 | $382k | 15.0% | Plan not stated | SEC |
| May 3, 2017 | May 5, 2017 | Steris plc | VP, Gen Counsel, and Sec. | Form 4 sale | 3,150 | $236k | 11.8% | Plan not stated | SEC |
| Dec 13, 2016 | Dec 14, 2016 | Steris plc | VP, Gen Counsel, and Sec. | Form 4 sale | 3,100 | $214k | 11.7% | Plan not stated | SEC |
| Nov 15, 2016 | Nov 16, 2016 | Steris plc | VP, Gen Counsel, and Sec. | Form 4 sale | 2,200 | $147k | 8.4% | Plan not stated | SEC |
| Nov 3, 2014 | Nov 3, 2014 | STERIS CORP | VP, Gen Counsel, and Sec. | Form 4 sale | 925 | $57k | 5.8% | Plan not stated | SEC |
| Jun 2, 2014 | Jun 3, 2014 | STERIS CORP | VP, Gen Counsel, and Sec. | Form 4 sale | 2,000 | $107k | 11.7% | Plan not stated | SEC |
| Nov 8, 2013 | Nov 12, 2013 | STERIS CORP | VP, Gen Counsel, and Sec. | Form 4 sale | 5,000 | $226k | 27.5% | Unusual | SEC |